{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:51:29Z","timestamp":1791625889986,"version":"4.3.4"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"\n Importance<\/jats:title>\n Benign breast disease (BBD) comprises approximately 75% of breast biopsy diagnoses. Surgical biopsy specimens diagnosed as nonproliferative (NP), proliferative disease without atypia (PDWA), or atypical hyperplasia (AH) are associated with increasing breast cancer (BC) risk; however, knowledge is limited on risk associated with percutaneously diagnosed BBD.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To estimate BC risk associated with BBD in the percutaneous biopsy era irrespective of surgical biopsy.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n In this retrospective cohort study, BBD biopsy specimens collected from January 1, 2002, to December 31, 2013, from patients with BBD at Mayo Clinic in Rochester, Minnesota, were reviewed by 2 pathologists masked to outcomes. Women were followed up from 6 months after biopsy until censoring, BC diagnosis, or December 31, 2021.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Benign breast disease classification and multiplicity by pathology panel review.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes<\/jats:title>\n The main outcome was diagnosis of BC overall and stratified as ductal carcinoma in situ (DCIS) or invasive BC. Risk for presence vs absence of BBD lesions was assessed by Cox proportional hazards regression. Risk in patients with BBD compared with female breast cancer incidence rates from the Iowa Surveillance, Epidemiology, and End Results (SEER) program were estimated.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 4819 female participants, median age was 51 years (IQR, 43-62 years). Median follow-up was 10.9 years (IQR, 7.7-14.2 years) for control individuals without BC vs 6.6 years (IQR, 3.7-10.1 years) for patients with BC. Risk was higher in the cohort with BBD than in SEER data: BC overall (standard incidence ratio [SIR], 1.95; 95% CI, 1.76-2.17), invasive BC (SIR, 1.56; 95% CI, 1.37-1.78), and DCIS (SIR, 3.10; 95% CI, 2.54-3.77). The SIRs increased with increasing BBD severity (1.42 [95% CI, 1.19-1.71] for NP, 2.19 [95% CI, 1.88-2.54] for PDWA, and 3.91 [95% CI, 2.97-5.14] for AH), comparable to surgical cohorts with BBD. Risk also increased with increasing lesion multiplicity (SIR: 2.40 [95% CI, 2.06-2.79] for \u22653 foci of NP, 3.72 [95% CI, 2.31-5.99] for \u22653 foci of PDWA, and 5.29 [95% CI, 3.37-8.29] for \u22653 foci of AH). Ten-year BC cumulative incidence was 4.3% for NP, 6.6% for PDWA, and 14.6% for AH vs an expected population cumulative incidence of 2.9%.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this contemporary cohort study of women diagnosed with BBD in the percutaneous biopsy era, overall risk of BC was increased vs the general population (DCIS and invasive cancer combined), similar to that in historical BBD cohorts. Development and validation of pathologic classifications including both BBD severity and multiplicity may enable improved BC risk stratification.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamasurg.2023.6382","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T11:01:01Z","timestamp":1702465261000},"page":"193","source":"Crossref","is-referenced-by-count":40,"title":["Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era"],"prefix":"10.1001","volume":"159","author":[{"given":"Mark E.","family":"Sherman","sequence":"first","affiliation":[{"name":"Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Vierkant","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey J.","family":"Winham","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine M.","family":"Vachon","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi M.","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pacheco-Spann","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"McCauley","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya L.","family":"Hoskin","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Seymour","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denice","family":"Gehling","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek C.","family":"Radisky","sequence":"additional","affiliation":[{"name":"Cancer Biology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Degnim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"soi230093r1","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/cncr.v121.9","article-title":"Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.","volume":"121","author":"Allison","year":"2015","journal-title":"Cancer"},{"issue":"11","key":"soi230093r2","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/1055-9965.EPI-20-0723","article-title":"Automated quantitative measures of terminal duct lobular unit involution and breast cancer risk.","volume":"29","author":"Kensler","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"soi230093r3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ijc.v145.2","article-title":"Benign breast disease increases breast cancer risk independent of underlying familial risk profile: findings from a prospective family study cohort.","volume":"145","author":"Zeinomar","year":"2019","journal-title":"Int J Cancer"},{"issue":"7","key":"soi230093r4","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/cncr.v124.7","article-title":"Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer.","volume":"124","author":"Nutter","year":"2018","journal-title":"Cancer"},{"issue":"3","key":"soi230093r5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10549-017-4347-9","article-title":"Association between lifestyle, menstrual\/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.","volume":"165","author":"Arthur","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"soi230093r6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-014-3208-z","article-title":"Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.","volume":"149","author":"Castells","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"soi230093r7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13058-021-01410-1","article-title":"Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.","volume":"23","author":"Figueroa","year":"2021","journal-title":"Breast Cancer Res"},{"issue":"1","key":"soi230093r8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41523-021-00225-9","article-title":"The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease.","volume":"7","author":"Beca","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"soi230093r9","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa119","article-title":"Deep learning image analysis of benign breast disease to identify subsequent risk of breast cancer.","volume":"5","author":"Vellal","year":"2021","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"1","key":"soi230093r10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13058-021-01395-x","article-title":"Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer.","volume":"23","author":"Rohan","year":"2021","journal-title":"Breast Cancer Res"},{"key":"soi230093r11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.breast.2020.09.005","article-title":"Differences in breast cancer risk after benign breast disease by type of screening diagnosis.","volume":"54","author":"Louro","year":"2020","journal-title":"Breast"},{"issue":"1","key":"soi230093r12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10549-014-2862-5","article-title":"Sclerosing adenosis and risk of breast cancer.","volume":"144","author":"Visscher","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"14","key":"soi230093r13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/jnci\/djt124","article-title":"Benign breast disease, mammographic breast density, and the risk of breast cancer.","volume":"105","author":"Tice","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"soi230093r14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10549-013-2535-9","article-title":"Radial scars and subsequent breast cancer risk: results from the Nurses\u2019 Health Studies.","volume":"139","author":"Aroner","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"soi230093r15","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1186\/bcr2624","article-title":"Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.","volume":"12","author":"Aroner","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"12","key":"soi230093r16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/1940-6207.CAPR-12-0175","article-title":"Benign breast disease and the risk of subsequent breast cancer in African American women.","volume":"5","author":"Cote","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"soi230093r17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/pubmed\/fdq001","article-title":"Benign breast disease and subsequent breast cancer: English record linkage studies.","volume":"32","author":"Goldacre","year":"2010","journal-title":"J Public Health (Oxf)"},{"issue":"6","key":"soi230093r18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10552-010-9508-7","article-title":"A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.","volume":"21","author":"Kabat","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"2","key":"soi230093r19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/tbj.2007.13.issue-2","article-title":"Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.","volume":"13","author":"Worsham","year":"2007","journal-title":"Breast J"},{"issue":"1","key":"soi230093r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-008-0198-8","article-title":"Risk factors for breast cancer from benign breast disease in a diverse population.","volume":"118","author":"Worsham","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"18, pt 1","key":"soi230093r21","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1158\/1078-0432.CCR-07-0928","article-title":"Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.","volume":"13","author":"Worsham","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"8","key":"soi230093r22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10552-008-9145-6","article-title":"History of benign breast disease and risk of breast cancer among women in China: a case-control study.","volume":"19","author":"Dorjgochoo","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"2","key":"soi230093r23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10549-007-9605-9","article-title":"Breast cancer risk in women with radial scars in benign breast biopsies.","volume":"108","author":"Berg","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"soi230093r24","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","article-title":"Stratification of breast cancer risk in women with atypia: a Mayo cohort study.","volume":"25","author":"Degnim","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"soi230093r25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/cncr.v109:2","article-title":"Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses\u2019 Health Study.","volume":"109","author":"Collins","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"soi230093r26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/00000478-200606000-00001","article-title":"An analysis of breast cancer risk in women with single, multiple, and atypical papilloma.","volume":"30","author":"Lewis","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"soi230093r27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer.","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"soi230093r28","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/jnci\/djhs105","article-title":"Lower-category benign breast disease and the risk of invasive breast cancer.","volume":"96","author":"Wang","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"soi230093r29","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jamcollsurg.2019.01.018","article-title":"Twenty-five year trends in the incidence of ductal carcinoma in situ in US women.","volume":"228","author":"Oseni","year":"2019","journal-title":"J Am Coll Surg"},{"issue":"12","key":"soi230093r30","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1001\/jama.2020.14590","article-title":"Trends in obesity prevalence by race and Hispanic origin\u20141999-2000 to 2017-2018.","volume":"324","author":"Ogden","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"soi230093r31","first-page":"1","article-title":"Births: final data for 2021.","volume":"72","author":"Osterman","year":"2023","journal-title":"Natl Vital Stat Rep"},{"issue":"4","key":"soi230093r32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/gme.0b013e3181f43404","article-title":"Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009.","volume":"18","author":"Tsai","year":"2011","journal-title":"Menopause"},{"issue":"6","key":"soi230093r33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"soi230093r34","first-page":"101","article-title":"The relative survival rate: a statistical methodology.","volume":"6","author":"Ederer","year":"1961","journal-title":"Natl Cancer Inst Monogr"},{"issue":"5","key":"soi230093r35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41416-021-01459-x","article-title":"Mammographic microcalcifications and risk of breast cancer.","volume":"125","author":"Azam","year":"2021","journal-title":"Br J Cancer"},{"issue":"5","key":"soi230093r36","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ijc.33302","article-title":"Predictors of mammographic microcalcifications.","volume":"148","author":"Azam","year":"2021","journal-title":"Int J Cancer"},{"issue":"1","key":"soi230093r37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-016-3908-7","article-title":"Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.","volume":"159","author":"Figueroa","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"22","key":"soi230093r38","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/djj439","article-title":"Age-related lobular involution and risk of breast cancer.","volume":"98","author":"Milanese","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"soi230093r39","first-page":"109","article-title":"Genomic changes in normal breast tissue in women at normal risk or at high risk for breast cancer.","volume":"10","author":"Danforth","year":"2016","journal-title":"Breast Cancer (Auckl)"},{"issue":"1","key":"soi230093r40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-017-0850-5","article-title":"Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.","volume":"19","author":"Guo","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"2","key":"soi230093r41","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr3170","article-title":"Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers.","volume":"14","author":"Yang","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"1","key":"soi230093r42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13058-022-01577-1","article-title":"Associations between quantitative measures of TDLU involution and breast tumor molecular subtypes among breast cancer cases in the Black Women\u2019s Health Study: a case-case analysis.","volume":"24","author":"Davis Lynn","year":"2022","journal-title":"Breast Cancer Res"},{"issue":"1","key":"soi230093r43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41523-021-00378-7","article-title":"Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning.","volume":"8","author":"de Bel","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"15","key":"soi230093r44","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.2015.13183","article-title":"Benefits and harms of breast cancer screening: a systematic review.","volume":"314","author":"Myers","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"soi230093r45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2214\/AJR.21.26349","article-title":"Implementation of abbreviated breast MRI for screening: AJR Expert Panel narrative review.","volume":"218","author":"Grimm","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"soi230093r46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110513","article-title":"Contrast-enhanced mammography in breast cancer screening.","volume":"156","author":"Coffey","year":"2022","journal-title":"Eur J Radiol"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2813028\/jamasurgery_sherman_2023_oi_230093_1707866546.26001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:02:26Z","timestamp":1707908546000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2813028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2023.6382","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}